Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Sonoma Pharmaceuticals, Inc., v. Collidion Inc., et al.,
Case Number:
3:17-cv-01459
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
May 21, 2018
Sonoma Pharma Can Likely Pursue Trade Secret Claims
A California federal judge on Monday said she's unlikely to grant drugmaker Collidion Inc.'s bid to trim rival Sonoma Pharmaceuticals Inc.'s trade secrets suit, saying the claims probably aren't time-barred and that it's too soon to say whether Sonoma was injured by the alleged theft.
-
June 27, 2017
Sonoma Pharma Beats Sanctions Bid Alleging Forged Letter
A California federal judge Tuesday shot down a sanctions motion by drugmaker Collidion alleging rival Sonoma Pharmaceuticals relied on a forged letter to bring its trade secret suit, saying the motion was filed too early and that other evidence suggests the allegations in the disputed document are accurate.
-
May 22, 2017
Trade Secrets Suit Based On Forged Letter, Pharma Co. Says
Sonoma Pharmaceuticals Inc. relied on a forged letter to bring a trade secrets suit against new rival Collidion Inc., so the suit should be tossed and Sonoma should be sanctioned, Collidion told a California federal judge Friday.